Showing results (2221-2230 of 10,003) with videos related to
Sort By:
Pageof 1,001
Leukemia & Lymphoma|April 5, 2018
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana LinfomiFrancesco Zaja, Flavia Salvi, Maura Rossi, et al.Leukemia & Lymphoma|June 19, 2018
Deferred treatment is a safe and viable option for selected patients with mantle cell lymphomaOscar Calzada, Jeffrey M Switchenko, Joseph J Maly, et al.Leukemia & Lymphoma|February 12, 2015
Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbiditiesOmur Gokmen Sevindik, Zeynep Guc, Selda Kahraman, et al.Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.Leukemia & Lymphoma|February 14, 2015
Medical complications, resource utilization and costs in patients with myelofibrosis by frequency of blood transfusion and iron chelation therapyFrancis Vekeman, Wendy Y Cheng, Medha Sasane, et al.Leukemia & Lymphoma|February 14, 2015
Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphomaJonathan Reiss, Brian Link, Jia Ruan, et al.Leukemia & Lymphoma|February 21, 2015
Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical courseGulsum Emel Pamuk, Hilmi Tozkir, Mehmet Sevki Uyanik, et al.Leukemia & Lymphoma|February 3, 2015
How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?Constantine S Tam, Stephan StilgenbauerLeukemia & Lymphoma|February 3, 2015
Flavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanismsYan-Lai Tang, Li-Bin Huang, Yun Tian, et al.Leukemia & Lymphoma|February 3, 2015
Risk assessment of second primary cancer according to histological subtype of non-Hodgkin lymphomaCédric Rossi, Jérémie Jégu, Morgane Mounier, et al.Pageof 1,001